Strategy Inc director exercises options, sells 3,400 shares
Strategy Inc director Jarrod M. Patten reported an exercise-and-sell transaction in Class A Common Stock.
Rhea-AI Filing Summary
Strategy Inc director Jarrod M. Patten reported an exercise-and-sell transaction in Class A Common Stock. On April 13, 2026, he exercised options to acquire a total of 3,400 shares at an exercise price of $18.654 per share and sold the same 3,400 shares in open-market transactions at prices around $130 per share. Following these moves, he held 28,000 Class A Common shares directly. The filing also lists direct holdings of 10,000 shares of Series A Perpetual Strife Preferred Stock, 29,335 shares of Series A Perpetual Stretch Preferred Stock, and 5,000 shares of Series A Perpetual Stride Preferred Stock.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Director Stock Option (Right to buy) | 1,400 | $0.00 | $0.00 |
| Exercise | Director Stock Option (Right to buy) | 2,000 | $0.00 | $0.00 |
| Exercise | Class A Common Stock | 1,400 | $18.654 | $26K |
| Sale | Class A Common Stock | 1,400 | $129.865 | $182K |
| Exercise | Class A Common Stock | 2,000 | $18.654 | $37K |
| Sale | Class A Common Stock | 2,000 | $131.191 | $262K |
| holding | Series A Perpetual Strife Preferred Stock | -- | -- | -- |
| holding | Series A Perpetual Stretch Preferred Stock | -- | -- | -- |
| holding | Series A Perpetual Stride Preferred Stock | -- | -- | -- |
Footnotes (2)
- F1. The 1,400 shares exercised on April 13, 2026 pursuant to this option vested on May 31, 2017. Of the remaining 41,800 shares subject to this option, 4,300 shares vested on May 31, 2017, 12,500 shares vested on May 31, 2018, 12,500 shares vested on May 31, 2019, and 12,500 shares vested on May 31, 2020.
- F2. The 2,000 shares exercised on April 13, 2026 pursuant to this option vested on May 31, 2017. Of the remaining 39,800 shares subject to this option, 2,300 shares vested on May 31, 2017, 12,500 shares vested on May 31, 2018, 12,500 shares vested on May 31, 2019, and 12,500 shares vested on May 31, 2020.
Key Figures
Key Terms
Director Stock Option (Right to buy) financial
Class A Common Stock financial
open-market sale financial
Series A Perpetual Strife Preferred Stock financial
Series A Perpetual Stretch Preferred Stock financial
Series A Perpetual Stride Preferred Stock financial
FAQ
What insider transactions did MSTR director Jarrod M. Patten report?
What option exercise price is shown in the MSTR Form 4 filing?
Does the Form 4 show any preferred stock holdings for the MSTR director?
AI-generated analysis. How Rhea-AI works. Not financial advice.